Cancer Research UK and Linguamatics Collaborate

News   Sep 03, 2015

 
Cancer Research UK and Linguamatics Collaborate
 
 
 

RELATED ARTICLES

Glythera Appoints Chief Scientific Officer and Strengthens SAB

News

Dr Robert Lutz appointed as CSO to support development of next-generation PermaLink® Antibody Drug Conjugates. Dr Jon Roffey appointed to Scientific Advisory Board.

READ MORE

New Treatment Target for Melanoma

News

Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma.

READ MORE

Missing Hormone Gene Linked to Incurable Prostate Cancer

News

A study has shown that the loss of a subtype of the gene HSD17B4 can contribute to treatment-resistant prostate cancer.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE